GWM
GMAB icon

Geneos Wealth Management’s Genmab GMAB Stock Holding History

Geneos Wealth Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-509
Closed -$10.5K – 2768
2025
Q2 		$10.5K Sell
509
-865
-63% -$17.8K ﹤0.01% 2310
2025
Q1 		$26.9K Buy
1,374
+1,130
+463% +$23.7K ﹤0.01% 2199
2024
Q4 		$5.09K Buy
+244
New +$5.36K ﹤0.01% 2328

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geneos Wealth Management's GMAB Position: Q3 2025 in Review

Geneos Wealth Management sold out of Genmab (GMAB) in Q3 2025, closing a stake of 509 shares — an estimated $10.5K sold.

Geneos Wealth Management first reported a position in GMAB in Q4 2024 and held it in 3 quarters. The position peaked at $26.9K in Q1 2025. 252 funds tracked by Wall St. Rank hold GMAB as of Q3 2025.

  • Geneos Wealth Management reported no remaining Genmab position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 509 Genmab shares in Q3 2025, an estimated $10.5K.
  • Geneos Wealth Management first reported a position in Genmab in Q4 2024 and held it in 3 quarters.
  • Geneos Wealth Management's Genmab position peaked at $26.9K in Q1 2025.
  • 252 funds tracked by Wall St. Rank held Genmab as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.